Back to search
FDAFDA · Food and drugs·Recall number D-1234-2014

1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.

Published April 23, 2014 · Recall initiated: September 16, 2013

Summary

FDA records drug Class I recall D-1234-2014, published April 23, 2014 and initiated September 16, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 374,500 vials; Lot: Lot #25090DK; Exp 01/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.

What to do

Voluntary: Firm initiated · Letter

Get an email if LIDOCAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOCAINE HYDROCHLORIDE
Manufacturer
Hospira, Inc.
Distributor
Nationwide
Lot
Lot #25090DK; Exp 01/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045. recalled?

Yes. FDA published recall D-1234-2014 on April 23, 2014. Reported hazard: Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.